Genetic variants of DNA repair pathway genes on lung cancer risk.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 03 05 2019
revised: 07 07 2019
accepted: 17 07 2019
pubmed: 25 7 2019
medline: 7 3 2020
entrez: 25 7 2019
Statut: ppublish

Résumé

As is commonly perceived, polymorphisms in genes of deoxyribonucleic acid (DNA) repair pathway plays a fundamental role in defective DNA repair and mutagenesis prevention and serves to contribute to the individual susceptibility to the development of a variety of cancers. Recently, an increasing number of studies have been dedicated to the contentious and ambiguous links between polymorphisms in genes of DNA repair pathway and lung cancer (LC) risk. In response, a comprehensive updated meta-analysis has been proposed herein to assess the correlation between polymorphisms of DNA repair pathway genes and susceptibility to LC. This paper has identified and retrieved eligible articles from PubMed, Google Scholar, Web of Science, and CNKI databases till February 20, 2019. Finally, 295 case-control studies as to the fourteen polymorphisms of DNA repair pathway genes were enrolled. When the results have been pooled, we have brought to light the conclusion that ERCC2-rs13181 polymorphism has an elevated association with LC risk under allele, heterozygote, and dominant comparisons. In the subgroup analysis by ethnicity, we have found that the Caucasian individuals with "B" variant possess risk of LC which was more than twice as much as allele, homozygote, and recessive models. In comparison, Asian carriers of rs13181 polymorphism in ERCC2 gene are more susceptible to LC in heterozygote, dominant models. To sum up, ERCC2-rs13181 polymorphism could be a critical factor in stimulating LC evolvement. Future studies with a larger sample size and multivariate factors are needed to vindicate these findings.

Identifiants

pubmed: 31337555
pii: S0344-0338(19)30832-5
doi: 10.1016/j.prp.2019.152548
pii:
doi:

Substances chimiques

Xeroderma Pigmentosum Group D Protein EC 3.6.4.12
ERCC2 protein, human EC 5.99.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

152548

Informations de copyright

Copyright © 2019. Published by Elsevier GmbH.

Auteurs

Wanzhen Li (W)

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Respiratory department, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China.

Meng Zhang (M)

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Respiratory department, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China.

Caojuan Huang (C)

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Respiratory department, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China.

Jalin Meng (J)

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Respiratory department, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China.

Xingxu Yin (X)

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Respiratory department, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China.

Gengyun Sun (G)

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Respiratory department, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China. Electronic address: sungengy@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH